HUP9700997A1 - Benzimidazolszármazékok és e vegyületeket tartalmazó, antihisztamin hatású gyógyászati készítmények - Google Patents

Benzimidazolszármazékok és e vegyületeket tartalmazó, antihisztamin hatású gyógyászati készítmények

Info

Publication number
HUP9700997A1
HUP9700997A1 HU9700997A HUP9700997A HUP9700997A1 HU P9700997 A1 HUP9700997 A1 HU P9700997A1 HU 9700997 A HU9700997 A HU 9700997A HU P9700997 A HUP9700997 A HU P9700997A HU P9700997 A1 HUP9700997 A1 HU P9700997A1
Authority
HU
Hungary
Prior art keywords
pipe powder
general formula
powder
ethyl
pharmaceutical compositions
Prior art date
Application number
HU9700997A
Other languages
English (en)
Inventor
Maravillas Bordell
Aurelio Orjales
Victor Rubio
Original Assignee
Fabrica Espanola De Productos Quimicos Y Farmaceuticos, S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fabrica Espanola De Productos Quimicos Y Farmaceuticos, S.A. filed Critical Fabrica Espanola De Productos Quimicos Y Farmaceuticos, S.A.
Publication of HU9700997D0 publication Critical patent/HU9700997D0/hu
Publication of HUP9700997A1 publication Critical patent/HUP9700997A1/hu
Publication of HU227598B1 publication Critical patent/HU227598B1/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

A találmány az (I) általánős képletű, antihisztaminhatásúvegyületekre, valamint azők gyógyászati szempőntból elfőgadhatósavakkal és bázisőkkal alkőtőtt addíciós sóira, valamint kezelésieljárásra vőnatkőzik. Az (I) általánős képletben R1 jelentése hidrőgénatőm vagy rövid szénláncú szénhidrőgéncsőpőrt,így metil-, etil-, izőprőpil-, ciklőprőpil- vagy vinilcsőpőrt; és R2 jelentése CH2OH, COOH, COOR3 általánős képletű csőpőrt vagy 4,4-dimetil-2-őxazőlinil-csőpőrt, ahől R3 jelentése rövid szénláncúalkilcsőpőrt, példáűl metil- vagy etilcsőpőrt. A találmány szerintivegyületek igen erős, szelektív H1-antihisztamin hatást ésantiallergiás hatást fejtenek ki, és különleges előnyük, hőgy számősmás antihisztamin közpőnti idegrendszeri és kardiővaszkűlárisrendszeren előidézett kárős mellékhatásaitól mentesek. ŕ
HU9700997A 1996-06-04 1997-06-04 Benzimidazole derivatives and antihistaminic pharmaceutical compositions containing them HU227598B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES09601236A ES2124167B1 (es) 1996-06-04 1996-06-04 Nuevos derivados del bencimidazol con actividad antihistaminica.

Publications (3)

Publication Number Publication Date
HU9700997D0 HU9700997D0 (en) 1997-07-28
HUP9700997A1 true HUP9700997A1 (hu) 1999-09-28
HU227598B1 HU227598B1 (en) 2011-09-28

Family

ID=8295035

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9700997A HU227598B1 (en) 1996-06-04 1997-06-04 Benzimidazole derivatives and antihistaminic pharmaceutical compositions containing them

Country Status (27)

Country Link
US (1) US5877187A (hu)
EP (1) EP0818454B1 (hu)
JP (1) JP4218991B2 (hu)
CN (1) CN1105716C (hu)
AR (1) AR008386A1 (hu)
AT (1) ATE264317T1 (hu)
AU (1) AU725700B2 (hu)
BR (1) BR9703276A (hu)
CA (1) CA2206754C (hu)
CZ (1) CZ289278B6 (hu)
DE (2) DE122011000006I1 (hu)
DK (1) DK0818454T3 (hu)
ES (1) ES2124167B1 (hu)
FR (1) FR11C0023I2 (hu)
HR (1) HRP970307B1 (hu)
HU (1) HU227598B1 (hu)
IN (1) IN186319B (hu)
LU (1) LU91798I2 (hu)
MX (1) MXPA97004127A (hu)
NO (2) NO313195B1 (hu)
PL (1) PL188908B1 (hu)
PT (1) PT818454E (hu)
RU (1) RU2182150C2 (hu)
SI (1) SI0818454T1 (hu)
TR (1) TR199700464A2 (hu)
TW (1) TW438794B (hu)
ZA (1) ZA974893B (hu)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL140422A0 (en) 1998-07-01 2002-02-10 Retinoid Related Receptor Func Retinoid-related receptor function regulating agent
SK285529B6 (sk) 1998-11-27 2007-03-01 Basf Aktiengesellschaft Substituované benzimidazoly, farmaceutická kompozícia s ich obsahom a ich použitie ako inhibítorov PARP
ES2151442B1 (es) * 1999-01-11 2001-07-01 Espanola Prod Quimicos Nuevo derivado del bencenoetanol.
US6826561B2 (en) 2000-05-22 2004-11-30 Broadcom Corporation Method and apparatus for performing a binary search on an expanded tree
AU2002255017B2 (en) * 2002-04-19 2008-11-13 Faes Farma, S.A. Polymorph of 4-[2-[4-[1-(2-ethoxyethyl)-1H-benzimidazole-2-yl]-1-piperidinyl]ethyl]-alpha, alpha-dimethyl-benzeneacetic acid
US20070188330A1 (en) * 2006-01-24 2007-08-16 Morhard Robert C System and method for detecting, monitoring, tracking and identifying explosive materials using ID marks
US7247623B2 (en) * 2005-08-19 2007-07-24 Inspire Pharmaceuticals, Inc. Method of treating dry eye disease with non-drying antihistamines
EP2240464A4 (en) 2008-02-12 2011-09-14 Yuhan Corp PROCESS FOR THE PREPARATION OF 2-METHYL-2'-PHENYLPROPIONIC ACID DERIVATIVES AND NOVEL INTERMEDIATE COMPOUNDS
JP2010013472A (ja) * 2009-09-09 2010-01-21 Faes Farma Sa ４−［２−［１−（２−エトキシエチル）−１Ｈ−ベンズイミダゾール−２−イル］−１−ピペリジニル］エチル］−α，α−ジメチルベンゼノ酢酸の多形体
CN102675101B (zh) * 2012-05-16 2014-01-29 王蕾 2-(4-卤乙基)苯基-2-甲基丙酸酯的制备方法及合成比拉斯汀的方法
CZ307500B6 (cs) 2012-08-15 2018-10-24 Zentiva, K.S. Způsob přípravy derivátu 2-methyl-2´-fenylpropionové kyseliny využívající nové intermediáty
US20140271504A1 (en) * 2013-03-15 2014-09-18 Hercules Incorporated Composition and method of producing personal care compositions with improved deposition properties
CN103214454A (zh) * 2013-03-30 2013-07-24 北京万全德众医药生物技术有限公司 一种比拉斯汀晶型及制备方法
CN103214455B (zh) * 2013-03-30 2018-08-31 北京万全德众医药生物技术有限公司 一种比拉斯汀的制备方法
WO2014188453A2 (en) * 2013-05-24 2014-11-27 Msn Laboratories Private Limited Novel process for the preparation of 2-[4-(2-{4-[1-(2-ethoxyethyl)-1h-benzimidazol-2-yl]-1-piperidinyl}ethyl) phenyl]-2-methylpropanoic acid
CN103351380B (zh) * 2013-06-30 2019-01-22 北京万全德众医药生物技术有限公司 一种制备比拉斯汀的方法
CN104447683A (zh) * 2013-09-12 2015-03-25 天津市汉康医药生物技术有限公司 一种稳定的比拉斯汀化合物
CN103896915A (zh) * 2014-04-01 2014-07-02 中国药科大学 苯并咪唑类衍生物、其制备方法及其在医药上的应用
EP3040334A1 (en) 2014-12-29 2016-07-06 Faes Farma, S.A. New benzimidazole derivatives as antihistamine agents
CN106349214B (zh) * 2015-07-13 2020-11-03 南京长澳医药科技有限公司 一种比拉斯汀杂质的制备方法
CN107849007A (zh) * 2015-07-24 2018-03-27 乌奎玛公司 比拉斯汀的晶型及其制备方法
CN105272977A (zh) * 2015-09-19 2016-01-27 万全万特制药江苏有限公司 一种制备比拉斯汀中间体的方法
EP3170816A1 (en) 2015-11-20 2017-05-24 Faes Farma, S.A. Supersaturated compositions of benzimidazole compounds
EP3170817A1 (en) 2015-11-20 2017-05-24 Faes Farma, S.A. Co-crystals of benzimidazole compounds
WO2017167949A1 (en) 2016-04-01 2017-10-05 Krka, D.D., Novo Mesto Crystalline forms of bilastine
EP3452462A4 (en) * 2016-05-05 2019-10-23 MSN Laboratories Private Limited, R&D Center SOLID STATE FORMS OF 2- [4- (2- {4- [1- (2-ETHOXYETHYL) -1H-BENZIMIDAZOL-2-YL] -1-PIPERIDINYL} ETHYL) PHENYL] -2-METHYLPROPANOIC ACID AND PREPARATION METHOD THEREOF
CN107365298A (zh) * 2017-03-14 2017-11-21 罗欣生物科技（上海）有限公司 一种2‑甲基‑2’‑苯基丙酸衍生物的制备方法
CN109456316A (zh) * 2017-09-06 2019-03-12 万全万特制药江苏有限公司 一种比拉斯汀杂质的制备方法
ES2813561T3 (es) 2017-09-07 2021-03-24 Tiefenbacher Alfred E Gmbh & Co Kg Composición farmacéutica en comprimido que comprende bilastina
MA50247B1 (fr) 2017-10-16 2021-02-26 Faes Farma Sa Compositions aqueuses comprenant de la bilastine et du mométasone
ES2773756R1 (es) 2017-12-18 2021-04-12 Tiefenbacher Alfred E Gmbh & Co Kg Composición farmacéutica en comprimido que comprende la forma 3 de bilastina y una carga soluble en agua
EP3470062B1 (en) 2017-12-18 2020-10-28 Alfred E. Tiefenbacher (GmbH & Co. KG) Pharmaceutical tablet composition comprising bilastine polymorphic form 3 and magnesium aluminometasilicate
MX2020007692A (es) 2018-01-18 2020-09-14 Faes Farma Sa Composiciones oftalmicas que comprenden bilastina, una beta-ciclodextrina y al menos un agente de gelificacion.
CN109081827A (zh) * 2018-11-06 2018-12-25 北京天弘天达医药科技股份有限公司 一种比拉斯汀的制备方法及应用
EP3725298A1 (en) 2019-04-16 2020-10-21 Faes Farma, S.A. Stable and preserved pharmaceutical compositions of bilastine
WO2022023463A1 (en) 2020-07-30 2022-02-03 Faes Farma, S.A. Decongestant drug delivery system
CN112110893A (zh) * 2020-10-28 2020-12-22 山东齐环医药科技有限公司 一种比拉斯汀的制备方法
JP2023549381A (ja) 2020-11-18 2023-11-24 バイオファーマ・シナジーズ，エス．エル． 抗ヒスタミン活性化合物を含む口内分散性粉末組成物
EP4267109A1 (en) 2020-12-23 2023-11-01 Noucor Health S.A. A non-micronized bilastine composition
WO2023156559A1 (en) 2022-02-17 2023-08-24 Faes Farma, S.A. Bilastine composition for once-daily parenteral administration

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2048109B1 (es) * 1992-07-20 1994-12-16 Espanola Prod Quimicos Procedimiento de preparacion de nuevos derivados piperidicos del bencimidazol.
RO116043B1 (ro) * 1992-08-03 2000-10-30 Sepracor Inc Compozitie farmaceutica
ES2190442T3 (es) * 1993-06-25 2003-08-01 Merrell Pharma Inc Nuevos productos intermedios para la preparacion de derivados de 4-difenilmetil/difenilmetoxi piperidina antihistaminicos.

Also Published As

Publication number Publication date
DE69728608D1 (de) 2004-05-19
TR199700464A3 (tr) 1997-12-21
LU91798I2 (fr) 2011-05-23
CZ172397A3 (en) 1997-12-17
TR199700464A2 (xx) 1997-12-21
ES2124167B1 (es) 1999-09-16
NO972525D0 (no) 1997-06-03
BR9703276A (pt) 2004-08-17
TW438794B (en) 2001-06-07
JP4218991B2 (ja) 2009-02-04
PL188908B1 (pl) 2005-05-31
CA2206754C (en) 2007-01-23
HU9700997D0 (en) 1997-07-28
FR11C0023I2 (fr) 2012-03-16
DE122011000006I1 (de) 2011-06-16
ATE264317T1 (de) 2004-04-15
HRP970307B1 (en) 2002-02-28
US5877187A (en) 1999-03-02
PT818454E (pt) 2004-08-31
NO313195B1 (no) 2002-08-26
CA2206754A1 (en) 1997-12-04
FR11C0023I1 (hu) 2011-08-19
NO972525L (no) 1997-12-05
MXPA97004127A (es) 2005-07-25
EP0818454B1 (en) 2004-04-14
HRP970307A2 (en) 1998-04-30
CN1105716C (zh) 2003-04-16
AR008386A1 (es) 2000-01-19
SI0818454T1 (en) 2004-08-31
NO2011008I1 (no) 2011-06-06
CN1176964A (zh) 1998-03-25
ES2124167A1 (es) 1999-01-16
IN186319B (hu) 2001-08-04
PL320358A1 (en) 1997-12-08
RU2182150C2 (ru) 2002-05-10
DK0818454T3 (da) 2004-07-12
CZ289278B6 (cs) 2001-12-12
JPH1059961A (ja) 1998-03-03
AU725700B2 (en) 2000-10-19
DE69728608T2 (de) 2005-04-21
NO2011008I2 (no) 2012-05-14
EP0818454A1 (en) 1998-01-14
AU2467297A (en) 1997-12-11
HU227598B1 (en) 2011-09-28
ZA974893B (en) 1997-12-30

Similar Documents

Publication Publication Date Title
HUP9700997A1 (hu) Benzimidazolszármazékok és e vegyületeket tartalmazó, antihisztamin hatású gyógyászati készítmények
DE3679474D1 (de) N6-disubstituierte purinderivate, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel.
KR880006229A (ko) 항궤양 활성을 갖는 피리딘 유도체
ES2112332T3 (es) Derivados de substitucion de oxigeno de productos de adicion de nucleofilo-oxido nitrico utilizados como promedicamentos donadores de oxido nitrico.
DE59407494D1 (de) 4-aminopyridine, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel
ATE127801T1 (de) Pyrazolopyridinverbindungen und verfahren zu ihrer herstellung.
KR960703858A (ko) 물질 p 길항제로서의 퍼히드로이소인돌 유도체(perhydroisoindole derivatives as substance p antagonists)
ES8704924A1 (es) Un procedimiento para la preparacion de derivados de benzotiazol y benzotiofeno
RU2000119731A (ru) Новые тетрациклические аналоги камптотецинов, способы их получения, их применение в качестве лекарств и фармацевтические композиции, их содержащие
NO934792L (no) Xantinderivater
DE3462504D1 (de) Indole-3-carboxamide derivatives
HUP9801838A2 (hu) Specifikus ingerlő aminosav antagonista indolszármazékok
FR2767525B1 (fr) Derives biphenyliques substitues par un radical aromatique ou heteroaromatique et compositions pharmaceutiques et cosmetiques les contenant
ECSP930953A (es) Nuevos derivados de indol
KR900011728A (ko) 5-리폭시게나제 억제제로서의 치환된 인돌, 벤조푸란 및 벤조티오펜 유도체
FI925801A0 (fi) Piperidyl-substituerade indoler
KR840003628A (ko) 피리딜화합물의 제조방법
HUP9700708A2 (hu) N-[(9-pirimido[1,2-a]indolil)-metil-fenil-acetil]-fenil-glicinol-származékok, az ezeket tartalmazó gyógyszerkészítmények, eljárás előállításukra és intermedierjeik
KR920007999A (ko) 4-또는 5-치환된 피리딘-2-카복실산. 이들의 제조방법 및 약제로서 이들의 용도
HUP0003861A2 (hu) Kinolin-4-il-származékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyászati készítmények
DE3574471D1 (de) 1,6-naphthyridin-derivate, verfahren zu deren herstellung und diese enthaltende arzneimittel.
DK0470686T3 (da) (Benzhydryloxyethylpiperidyl)alifatiske syrederivater og deres anvendelse til behandling af allergier og astma
ATE112562T1 (de) Acylbenzoxazolinone, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen die sie enthalten.
FI923841A (fi) Substituerade mandelsyraderivat, foerfarande foer deras framstaellning och deras anvaendning som laekemedel
ES407816A1 (es) Metodo para producir derivados de benzodiazepina.

Legal Events

Date Code Title Description
AA1S Information on application for a supplementary protection certificate

Free format text: PRODUCT NAME: BILASTIN AND IT'S PHARMACEUTICALLY ACCEPTABLE ALKALINE OR ACID ADDITION SALTS; REG. NO/DATE: OGYI-T-21640/01-03 20110224; FIRST REG. NO: IS/1/10/002/01 20100923

Spc suppl protection certif: S1100021

Filing date: 20111013

Expiry date: 20170604

Free format text: PRODUCT NAME: BILASTIN AND IT'S PHARMACEUTICALLY ACCEPTABLE ALKALINE OR ACID ADDITION SALTS; REG. NO/DATE: OGYI-T-21640/01-03 20110224; FIRST REG.: EU IS/1/10/002/01 20100923

Spc suppl protection certif: S1100021

Filing date: 20111013

Expiry date: 20170604

FG4S Grant of supplementary protection certificate

Free format text: PRODUCT NAME: BILASTIN AND IT'S PHARMACEUTICALLY ACCEPTABLE ALKALINE OR ACID ADDITION SALTS; REG. NO/DATE: OGYI-T-21640/01-03 20110224; FIRST REG. NO: IS/1/10/002/01 20100923

Spc suppl protection certif: S1100021

Filing date: 20111013

Expiry date: 20170604

Extension date: 20220604